Synthesis and antiamnesic activity of a series of N-acylprolyl-containing dipeptides TA Gudasheva, TA Voronina, RU Ostrovskaya, GG Rozantsev, ... European journal of medicinal chemistry 31 (2), 151-157, 1996 | 151 | 1996 |
Examination of the 1, 4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design L Sun, NI Vasilevich, JA Fuselier, SJ Hocart, DH Coy Bioorganic & medicinal chemistry letters 14 (9), 2041-2046, 2004 | 88 | 2004 |
Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors DO Koltun, EQ Parkhill, NI Vasilevich, AI Glushkov, TM Zilbershtein, ... Bioorganic & medicinal chemistry letters 19 (7), 2048-2052, 2009 | 67 | 2009 |
Lessons from Natural Products Chemistry Can Offer Novel Approaches for Synthetic Chemistry in Drug Discovery: Miniperspective NI Vasilevich, RV Kombarov, DV Genis, MA Kirpichenok Journal of Medicinal Chemistry 55 (16), 7003-7009, 2012 | 61 | 2012 |
An adjustable release rate linking strategy for cytotoxin–peptide conjugates JA Fuselier, L Sun, SN Woltering, WA Murphy, N Vasilevich, DH Coy Bioorganic & medicinal chemistry letters 13 (5), 799-803, 2003 | 50 | 2003 |
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS D Koltun, E Parkhill, M Boze, J Zablocki, N Vasilevich, E Mayboroda, ... US Patent App. 12/252,057, 2009 | 48 | 2009 |
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS D Koltun, E Parkhill, M Boze, J Zablocki, N Vasilevich, E Mayboroda, ... US Patent App. 12/100,399, 2008 | 48 | 2008 |
Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors DO Koltun, NI Vasilevich, EQ Parkhill, AI Glushkov, TM Zilbershtein, ... Bioorganic & medicinal chemistry letters 19 (11), 3050-3053, 2009 | 45 | 2009 |
Mild and Direct C–H Arylation of Quinoxalin-2 (1H)-ones with Aryldiazonium Salts under Metal-Free Conditions K Yin, R Zhang Synlett 29 (05), 597-602, 2018 | 44 | 2018 |
Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors DO Koltun, TM Zilbershtein, VA Migulin, NI Vasilevich, EQ Parkhill, ... Bioorganic & medicinal chemistry letters 19 (15), 4070-4074, 2009 | 33 | 2009 |
Abilities of 3, 4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice L Sun, NI Vasilevich, JA Fuselier, DH Coy Anticancer research 24 (1), 179-186, 2004 | 23 | 2004 |
Pteridinone derivatives for use as stearoyl CoA desaturase inhibitors J Chisholm, D Koltun, J Zablocki, E Parkhill, A Glushkov, N Vasilevich, ... US Patent 7,662,819, 2010 | 20 | 2010 |
Pyridol [2, 3-B] pyrazinones for use as stearoyl CoA desaturase inhibitors D Koltun, J Zablocki, E Parkhill, A Glushkov, N Vasilevich, T Zilbershtein, ... US Patent 7,893,066, 2011 | 19* | 2011 |
Efficient synthesis of 5-substituted 2-aryl-6-cyanoindolizines via nucleophilic substitution reactions EV Babaev, NI Vasilevich, AS Ivushkina Beilstein Journal of Organic Chemistry 1 (1), 9, 2005 | 18 | 2005 |
Synthesis and nootropic activity of pyrrolidino [1, 2-a] diazacycloalkanes TA Gudasheva, NI Vasilevich, RU Ostrovskaya, SS Trofimov, TA Voronina, ... Pharmaceutical chemistry journal 30, 562-567, 1996 | 16 | 1996 |
Selective conversion of O-succinimidyl carbamates to N-(O-carbamoyl)-succinmonoamides and ureas NI Vasilevich, ND Sachinvala, K Maskos, DH Coy Tetrahedron Letters 43 (18), 3443-3445, 2002 | 15* | 2002 |
Search for Potent and Selective Aurora A Inhibitors Based on General Ser/Thr Kinase Pharmacophore Model NI Vasilevich, VV Tatarskiy, EA Aksenova, ... Pharmaceuticals 9 (2), 19, 2016 | 13 | 2016 |
2H-BENZO [b][1, 4] OXAZIN-3 (4H)-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS D Koltun, J Zablocki, N Vasilevich, V Migulin US Patent App. 12/417,854, 2009 | 12 | 2009 |
Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA β-lactams J Pohlmann, NI Vasilevich, AI Glushkov, L Kellenberger, S Shapiro, ... Bioorganic & medicinal chemistry letters 20 (15), 4635-4638, 2010 | 11 | 2010 |
General Ser/Thr Kinases Pharmacophore Approach For Selective Kinase Inhibitors Search As Exemplified By Design Of Potent And Selective Aurora A Inhibitors NI Vasilevich, EA Aksenova, DN Kazyulkin, II Afanasyev Chem.Biology & Drug Design, 2016 | 9 | 2016 |